Neos

NEOS NASDAQ
1.410
0.000
0.00%
Closed 16:00 07/19 EDT
Open
1.410
Prev Close
1.410
High
1.440
Low
1.400
Volume
104.83K
Avg Vol (3M)
442.76K
52 Week High
6.30
52 Week Low
1.130
% Turnover
0.21%
Market Cap
70.11M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Neos NEOS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.
MORE >

Recently

Name
Price
%Change